Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring

BACKGROUND: Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver malignancies, and technological advances have improved it...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Lee, Yoo Young Dominique, Nguyen, Doan Trang, Moodie, Trevor, O’Brien, Ricky, McMaster, Anne, Hickey, Andrew, Pritchard, Nicole, Poulsen, Per, Tabaksblat, Elizaveta Mitkina, Weber, Britta, Worm, Esben, Pryor, David, Chu, Julie, Hardcastle, Nicholas, Booth, Jeremy, Gebski, Val, Wang, Tim, Keall, Paul
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2021
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8091536/
https://ncbi.nlm.nih.gov/pubmed/33941111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08184-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares